Cargando…
Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer’s Disease
Alzheimer’s disease (AD) is the most common form of dementia and aging is the most common risk factor for developing the disease. The etiology of AD is not known but AD may be considered as a clinical syndrome with multiple causal pathways contributing to it. The amyloid cascade hypothesis, claiming...
Autores principales: | Fulop, Tamas, Tripathi, Shreyansh, Rodrigues, Serafim, Desroches, Mathieu, Bunt, Ton, Eiser, Arnold, Bernier, Francois, Beauregard, Pascale B, Barron, Annelise E, Khalil, Abdelouahed, Plotka, Adam, Hirokawa, Katsuiku, Larbi, Anis, Bocti, Christian, Laurent, Benoit, Frost, Eric H, Witkowski, Jacek M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106529/ https://www.ncbi.nlm.nih.gov/pubmed/33976546 http://dx.doi.org/10.2147/NDT.S264910 |
Ejemplares similares
-
Can an Infection Hypothesis Explain the Beta Amyloid Hypothesis of Alzheimer’s Disease?
por: Fulop, Tamas, et al.
Publicado: (2018) -
Hyperactivation of monocytes and macrophages in MCI patients contributes to the progression of Alzheimer's disease
por: Munawara, Usma, et al.
Publicado: (2021) -
Immunosenescence and Altered Vaccine Efficiency in Older Subjects: A Myth Difficult to Change
por: Fulop, Tamas, et al.
Publicado: (2022) -
Are We Ill Because We Age?
por: Fulop, Tamas, et al.
Publicado: (2019) -
Immunosupportive therapies in aging
por: Fülöp, Tamas, et al.
Publicado: (2007)